Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €158.18 EUR
Change Today +1.03 / 0.65%
Volume 100.0
XP2 On Other Exchanges
As of 1:40 PM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Adam C. Derbyshire

Former Chief Financial Officer, Principal Accounting Officer and Executive Vice President of Finance & Administration, Salix Pharmaceuticals Ltd.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 3 different industries.

As of Fiscal Year 2013


Mr. Adam C. Derbyshire served as the Chief Financial Officer and Executive Vice President of Finance & Administration at Salix Pharmaceuticals Ltd. from January 2001 to November 2014 and served as its Principal Accounting Officer until November 2014. Mr. Derbyshire joined Salix in June 2000 and has extensive pharmaceutical industry experience in finance, accounting, investor relations, and general corporate matters. Previously, Mr. Derbyshire served as a Senior Vice ...

Read Full Background

Corporate Headquarters*

8510 Colonnade Center Drive
Raleigh, North Carolina 27615

United States

Phone: 919-862-1000
Fax: 919-862-1095

Board Members Memberships*

There is no Board Members Memberships data available.


University Of North Carolina At Wilmington
University of North Carolina at Charlotte

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
XP2:GR €158.18 EUR +1.03


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SALIX PHARMACEUTICALS LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at